Mettler-Toledo International, Inc.

MTD Healthcare Diagnostics & Research

Mettler-Toledo International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 3.98% from fiscal 2024.

Revenue
+6.27%
EPS
+16.2%
Free cash flow
+33.0%
Total debt
−8.42%

Quarter to September 2026, against a year earlier

1,749.08 70.00 +4.17%
Market cap
$33.6B
P/E
37.7×
Fwd P/E
36.1×
Dividend yield
—
F-score
5/9
Altman Z
10.23
Beneish M
−2.44
Dividend safety
n/a

Mettler-Toledo International, Inc. 10-Q filed Aug 1, 2025

Fiscal Q2 2024 · Period ended Jun 30, 2025 · Filed · accepted 2:52 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed May 2, 2025: 17 added · 17 removed · 38 modified; 5 with only figures updated

  1. Modified · General

    Our interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. Operating results for the three and six months ended March 31June 30, 2025 are not necessarily indicative of the results to be expected for the full year ending December 31, 2025.